Myriad Genetics (MYGN) Operating Margin: History & Chart

Myriad Genetics, Inc.(MYGN)

Medical - Diagnostics & Research · Salt Lake City, UT

$4.37-0.21 (-4.69%)

Delayed quote: Oct 6, 2026, 12:50 PM EDT

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Salt Lake City, UT

2,700 employees

www.myriad.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Samraat S. Raha

View full financials

MYGN Operating Margin Metrics

OPERATING MARGIN

-12.22%

OPERATING MARGIN AVG TTM

-40.85%

OPERATING MARGIN AVG 3Y

-15.20%

OPERATING MARGIN AVG 5Y

-19.41%

OPERATING MARGIN AVG 10Y

-10.29%

OPERATING MARGIN AVG 15Y

2.58%

OPERATING MARGIN AVG 20Y

5.09%

CURRENT VS TTM AVG

+70.08%

CURRENT VS 3Y AVG

+19.59%

CURRENT VS 5Y AVG

+37.03%

CURRENT VS 10Y AVG

-18.78%

CURRENT VS 15Y AVG

-573.76%

CURRENT VS 20Y AVG

-340.29%

SECTOR MEDIAN · HEALTHCARE

0.00%

median of 777 covered companies

CURRENT VS SECTOR MEDIAN

N/A

vs the sector median at left

NAME	MARKET CAP	OPERATING MARGIN	TTM	3Y	5Y
Myriad Genetics, Inc. (MYGN)	$412.27M	-12.22%	-40.85%	-15.20%	-19.41%
Shoulder Innovations, Inc. (SI)vs ›	$409.89M	-58.53%	-50.96%	-52.76%	-52.76%
Strata Critical Medical, Inc. (SRTA)vs ›	$410.57M	-7.97%	-12.49%	-22.96%	-27.91%
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$409.35M	0.00%	0.00%	0.00%	2.78%
Neurogene Inc. (NGNE)vs ›	$409.36M	0.00%	-4465.14%	-2232.57%	-1488.38%
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$410.53M	0.00%	0.00%	0.00%	0.00%
Prothena Corporation plc (PRTA)vs ›	$415.68M	-1905.82%	-1010.09%	-618.33%	-2608.93%
Rezolute, Inc. (RZLT)vs ›	$417.43M	0.00%	0.00%	0.00%	0.00%
Carlsmed, Inc. (CARL)vs ›	$406.69M	-61.09%	-74.66%	-94.75%	-94.75%
Senseonics Holdings, Inc. (SENS)vs ›	$418.99M	-193.83%	-263.44%	-320.82%	-550.06%

NAME

MARKET CAP

OPERATING MARGIN

TTM

Myriad Genetics, Inc. (MYGN)

$412.27M

-12.22%

-40.85%

-15.20%

-19.41%

Shoulder Innovations, Inc. (SI)vs ›

$409.89M

-58.53%

-50.96%

-52.76%

Strata Critical Medical, Inc. (SRTA)vs ›

$410.57M

-7.97%

-12.49%

-22.96%

-27.91%

Atea Pharmaceuticals, Inc. (AVIR)vs ›

$409.35M

0.00%

2.78%

Neurogene Inc. (NGNE)vs ›

$409.36M

0.00%

-4465.14%

-2232.57%

-1488.38%

Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›

$410.53M

0.00%

Prothena Corporation plc (PRTA)vs ›

$415.68M

-1905.82%

-1010.09%

-618.33%

-2608.93%

Rezolute, Inc. (RZLT)vs ›

$417.43M

0.00%

Carlsmed, Inc. (CARL)vs ›

$406.69M

-61.09%

-74.66%

-94.75%

Senseonics Holdings, Inc. (SENS)vs ›

$418.99M

-193.83%

-263.44%

-320.82%

-550.06%

Operating Margin FAQ

What is the operating margin for Myriad Genetics, Inc. (MYGN)?

The operating margin for MYGN stock is -12.22%.

Is Myriad Genetics, Inc.'s operating margin high or low?

The operating margin of -12.22% is 37% above its 5-year average of -19.41%, near the high end of its 5-year range (-154.48%–-2.72%).

What is the TTM average operating margin for Myriad Genetics, Inc. (MYGN)?

The TTM average operating margin for MYGN stock is -40.85%.

What is the 3Y average operating margin for Myriad Genetics, Inc. (MYGN)?

The 3Y average operating margin for MYGN stock is -15.20%.

What is the 5Y average operating margin for Myriad Genetics, Inc. (MYGN)?

The 5Y average operating margin for MYGN stock is -19.41%.

What is the 10Y average operating margin for Myriad Genetics, Inc. (MYGN)?

The 10Y average operating margin for MYGN stock is -10.29%.

What is the 15Y average operating margin for Myriad Genetics, Inc. (MYGN)?

The 15Y average operating margin for MYGN stock is 2.58%.

What is the 20Y average operating margin for Myriad Genetics, Inc. (MYGN)?

The 20Y average operating margin for MYGN stock is 5.09%.

DATE	OPERATING MARGIN
2026-06-30	-20.40%
2026-03-31	-15.32%
2025-12-31	-2.72%
2025-09-30	-11.33%
2025-06-30	-154.48%
2025-03-31	-14.80%
2024-12-31	-18.52%
2024-09-30	-9.38%
2024-06-30	-17.26%
2024-03-31	-13.80%
2023-12-31	-15.97%
2023-09-30	-31.32%
2023-06-30	-61.96%
2023-03-31	-28.81%
2022-12-31	-29.36%
2022-09-30	-28.77%
2022-06-30	-9.93%
2022-03-31	-15.52%
2021-12-31	-26.80%
2021-09-30	-47.76%
2021-06-30	-10.98%
2021-03-31	-26.98%
2020-12-31	0.00%
2020-09-30	-27.27%
2020-06-30	-73.28%
2020-03-31	-81.52%
2019-12-31	-4.51%
2019-09-30	-11.22%
2019-06-30	-2.60%
2019-03-31	2.72%
2018-12-31	2.81%
2018-09-30	0.59%
2018-06-30	4.98%
2018-03-31	7.54%
2017-12-31	3.35%
2017-09-30	46.98%
2017-06-30	8.48%
2017-03-31	3.91%
2016-12-31	8.65%
2016-09-30	3.21%
2016-06-30	19.10%
2016-03-31	22.36%
2015-12-31	23.38%
2015-09-30	23.60%
2015-06-30	19.06%
2015-03-31	19.83%
2014-12-31	19.69%
2014-09-30	15.34%
2014-06-30	28.21%
2014-03-31	30.22%
2013-12-31	40.67%
2013-09-30	40.95%
2013-06-30	37.86%
2013-03-31	37.01%
2012-12-31	37.27%
2012-09-30	36.41%
2012-06-30	35.56%
2012-03-31	35.52%
2011-12-31	37.02%
2011-09-30	37.55%
2011-06-30	38.89%
2011-03-31	40.85%
2010-12-31	38.42%
2010-09-30	38.75%
2010-06-30	40.05%
2010-03-31	36.58%
2009-12-31	37.21%
2009-09-30	34.91%
2009-06-30	90.20%
2009-03-31	40.75%
2008-12-31	39.69%
2008-09-30	18.07%
2008-06-30	39.68%
2008-03-31	-12.65%
2007-12-31	-15.40%
2007-09-30	-24.00%
2007-06-30	-26.97%
2007-03-31	-22.19%
2006-12-31	30.62%
2006-09-30	-44.72%
2006-06-30	-43.66%
2006-03-31	-40.10%
2005-12-31	-35.13%
2005-09-30	-40.03%
2005-06-30	-33.50%
2005-03-31	-53.65%
2004-12-31	-54.36%
2004-09-30	-63.54%
2004-06-30	-72.47%
2004-03-31	-81.16%
2003-12-31	-73.37%
2003-09-30	-74.37%
2003-06-30	-48.87%
2003-03-31	-37.98%
2002-12-31	-44.00%
2002-09-30	-39.15%

DATE

OPERATING MARGIN

2026-06-30

-20.40%

2026-03-31

-15.32%

2025-12-31

-2.72%

2025-09-30

-11.33%

2025-06-30

-154.48%

2025-03-31

-14.80%

2024-12-31

-18.52%

2024-09-30

-9.38%

2024-06-30

-17.26%

2024-03-31

-13.80%

2023-12-31

-15.97%

2023-09-30

-31.32%

2023-06-30

-61.96%

2023-03-31

-28.81%

2022-12-31

-29.36%

2022-09-30

-28.77%

2022-06-30

-9.93%

2022-03-31

-15.52%

2021-12-31

-26.80%

2021-09-30

-47.76%

2021-06-30

-10.98%

2021-03-31

-26.98%

2020-12-31

0.00%

2020-09-30

-27.27%

2020-06-30

-73.28%

2020-03-31

-81.52%

2019-12-31

-4.51%

2019-09-30

-11.22%

2019-06-30

-2.60%

2019-03-31

2.72%

2018-12-31

2.81%

2018-09-30

0.59%

2018-06-30

4.98%

2018-03-31

7.54%

2017-12-31

3.35%

2017-09-30

46.98%

2017-06-30

8.48%

2017-03-31

3.91%

2016-12-31

8.65%

2016-09-30

3.21%

2016-06-30

19.10%

2016-03-31

22.36%

2015-12-31

23.38%

2015-09-30

23.60%

2015-06-30

19.06%

2015-03-31

19.83%

2014-12-31

19.69%

2014-09-30

15.34%

2014-06-30

28.21%

2014-03-31

30.22%

2013-12-31

40.67%

2013-09-30

40.95%

2013-06-30

37.86%

2013-03-31

37.01%

2012-12-31

37.27%

2012-09-30

36.41%

2012-06-30

35.56%

2012-03-31

35.52%

2011-12-31

37.02%

2011-09-30

37.55%

2011-06-30

38.89%

2011-03-31

40.85%

2010-12-31

38.42%

2010-09-30

38.75%

2010-06-30

40.05%

2010-03-31

36.58%

2009-12-31

37.21%

2009-09-30

34.91%

2009-06-30

90.20%

2009-03-31

40.75%

2008-12-31

39.69%

2008-09-30

18.07%

2008-06-30

39.68%

2008-03-31

-12.65%

2007-12-31

-15.40%

2007-09-30

-24.00%

2007-06-30

-26.97%

2007-03-31

-22.19%

2006-12-31

30.62%

2006-09-30

-44.72%

2006-06-30

-43.66%

2006-03-31

-40.10%

2005-12-31

-35.13%

2005-09-30

-40.03%

2005-06-30

-33.50%

2005-03-31

-53.65%

2004-12-31

-54.36%

2004-09-30

-63.54%

2004-06-30

-72.47%

2004-03-31

-81.16%

2003-12-31

-73.37%

2003-09-30

-74.37%

2003-06-30

-48.87%

2003-03-31

-37.98%

2002-12-31

-44.00%

2002-09-30

-39.15%

Operating Margin: -12.22%

MYGN Operating Margin

MYGN Average Operating Margin Chart

MYGN Current vs Average Operating Margin Chart

MYGN Operating Margin Metrics

MYGN Competitors' Operating Margin

Operating Efficiency

Operating Margin Formula & Definition

Operating Margin FAQ

MYGN Operating Margin History

Related Metrics